Working… Menu

Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon (LB-04-THAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01642758
Recruitment Status : Completed
First Posted : July 17, 2012
Last Update Posted : March 14, 2013
HemaQuest Pharmaceuticals Inc.
Information provided by (Responsible Party):
Boston University